APA (7th ed.) Citation

Emoto, C., Fukuda, T., Venkatasubramanian, R., & Vinks, A. A. (2015). The impact of CYP3A53 polymorphism on sirolimus pharmacokinetics: Insights from predictions with a physiologically‐based pharmacokinetic model. British journal of clinical pharmacology, 80(6), 1438-1446. https://doi.org/10.1111/bcp.12743

Chicago Style (17th ed.) Citation

Emoto, Chie, Tsuyoshi Fukuda, Raja Venkatasubramanian, and Alexander A. Vinks. "The Impact of CYP3A53 Polymorphism on Sirolimus Pharmacokinetics: Insights from Predictions with a Physiologically‐based Pharmacokinetic Model." British Journal of Clinical Pharmacology 80, no. 6 (2015): 1438-1446. https://doi.org/10.1111/bcp.12743.

MLA (9th ed.) Citation

Emoto, Chie, et al. "The Impact of CYP3A53 Polymorphism on Sirolimus Pharmacokinetics: Insights from Predictions with a Physiologically‐based Pharmacokinetic Model." British Journal of Clinical Pharmacology, vol. 80, no. 6, 2015, pp. 1438-1446, https://doi.org/10.1111/bcp.12743.